It’s time for Unwrapped 2025. Explore pharma’s defining moments, our Word of the Year and a challenging brain teaser.

Daiichi Sankyo’s Dr Michael Zaiac discusses how AI, biomarkers and targeted therapies are shaping oncology.

Spain’s pharma sector is a hub for clinical trials, exports and digital innovation, but access and value-based reforms remain key.

In our latest Catalyst interview, AstraZeneca’s Dr Vikram Chand delves into improving outcomes in triple negative breast cancer and more.

Benedikt von Thüngen, Founder and CEO, Sanome, shares the origin story of his business, its biggest challenge to date and what pharma needs to know about AI.

As HCPs seek richer learning experiences, interactive patient case studies are bridging the gap between data and real-world practice.

Two UK health leaders reveal how to boost life sciences R&D, attract investment and make the UK a global hub for innovation once more.

On World Mental Health Day, our latest Catalyst Dr Volker Koscielny calls for a new approach in dermatology – where well-being matters as much as clinical outcomes.